Moderna | MRNA - Beneficio Operativo





Beneficio Operativo Cambio Fecha
Acadia Pharmaceuticals USD 37.84M 42.45M 2026-06
Agios Pharmaceuticals USD -110.02M 11.55M 2026-03
Alnylam Pharmaceuticals USD 112.6M 24.99M 2026-06
Amgen USD 4.61B 777M 2026-06
Arrowhead Research USD -170.09M 28.83M 2026-06
Biogen USD -243.8M 758.1M 2026-06
BioMarin Pharmaceutical USD 105.6M 24.04M 2026-06
Celltrion KRW 12.9B 822.77M 2026-03
Cspc Pharmaceutical CNY 206.26M 1.02B 2025-12
Deva Holding AS TRY 964.87M 240.32M 2023-09
Dianthus Therapeutics USD -46.53M 23.01M 2026-03
Divis Laboratories Ltd INR 11.29B 3.15B 2026-06
Gilead Sciences USD 3.85B 1.17B 2026-06
GlaxoSmithKline GBP 2.6B 312M 2026-06
Incyte USD 700.4M 376.22M 2026-06
Ionis Pharmaceuticals USD -102.29M 15.71M 2026-06
Kangmei Pharma CNY -10.94M 15.75M 2026-03
Knight Therapeutics CAD 6.21M 3.27M 2025-12
Laboratorios Farma EUR 135.05M 49.84M 2023-12
Malin Corporation EUR -1.1M 400K 2024-12
Moderna USD -815M 573M 2026-06
Organigram Holdings CAD -9.79M 10.33M 2026-03
Ovoca Bio EUR -173K 990K 2025-12
Pharma Mar EUR -1.4M 2.03M 2026-06
Puma Biotechnology USD 22.08M 24.26M 2024-09
Qiagen NV USD 141.4M 24.77M 2026-06
Regeneron Pharmaceuticals USD 1.42B 675.7M 2026-06
Sangamo BioSciences USD -33.51M 12.77M 2024-06
Sarepta Therapeutics USD 13.29M 345.14M 2026-06
Sartorius EUR 164M 3.3M 2026-06
Sino Biopharmaceutical CNY 5.18B 3.32B 2025-06
Tilray USD -20.01M 9.34M 2025-09
Ultragenyx Pharmaceutical USD -75M 141M 2026-06
United Therapeutics USD 330.8M 5M 2026-06
Vertex Pharmaceuticals USD 1.27B 129.9M 2026-06
Zealand Pharma A/S -539M 168.05M 2026-03
Zz Pientze Pharmaceu CNY 837.81M 336.48M 2026-03